Company Medite Cancer Diagnostics Inc OTC Bulletin Board
Equities
US58503D2009
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Rencher
SAM | Sales & Marketing | 56 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joel Kanter
BRD | Director/Board Member | 67 | - |
William Lewis
CHM | Chairman | 48 | 11/02/16 |
John H. Abeles
BRD | Director/Board Member | 78 | 30/04/99 |
Greg Fortunoff
BRD | Director/Board Member | 54 | 01/01/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 19,022 | 0 | 0 | 99.75 % |
Stock B | 0 | 38,333 | 0 | 0 | |
Stock C | 0 | 93,750 | 0 | 0 | |
Stock D | 1 | 86,742,909 | 86,723,700 ( 99.98 %) | 19,209 ( 0.0221 %) | |
Stock E | 0 | 47,250 | 0 | 0 |
Company contact information
MEDITE Cancer Diagnostics, Inc.
10524 Moss Park Road Suite 204-357
32832, Orlando
+
http://www.medite-group.comSector
1st Jan change | Capi. | |
---|---|---|
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- Stock
- Stock
- Company Medite Cancer Diagnostics Inc